15
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Yellow Fluorescent Protein-Based Assay to Measure GABA A Channel Activation and Allosteric Modulation in CHO-K1 Cells

      research-article
      , , *
      PLoS ONE
      Public Library of Science

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          The γ-aminobutyric acid A (GABA A) ion channels are important drug targets for treatment of neurological and psychiatric disorders. Finding GABA A channel subtype selective allosteric modulators could lead to new improved treatments. However, the progress in this area has been obstructed by the challenging task of developing functional assays to support screening efforts and the generation of cells expressing functional GABA A ion channels with the desired subtype composition. To address these challenges, we developed a yellow fluorescent protein (YFP)-based assay to be able to study allosteric modulation of the GABA A ion channel using cryopreserved, transiently transfected, assay-ready cells. We show for the first time how the MaxCyte STX electroporation instrument can be used to generate CHO-K1 cells expressing functional GABA A α2β3γ2 along with a halide sensing YFP-H148Q/I152L (YFP-GABA A2 cells). As a basis for a cell-based assay capable of detecting allosteric modulators, experiments with antagonist, ion channel blocker and modulators were used to verify GABA A subunit composition and functionality. We found that the I concentration used in the YFP assay affected both basal quench of YFP and potency of GABA. For the first time the assay was used to study modulation of GABA with 7 known modulators where statistical analysis showed that the assay can distinguish modulatory pEC 50 differences of 0.15. In conclusion, the YFP assay proved to be a robust, reproducible and inexpensive assay. These data provide evidence that the assay is suitable for high throughput screening (HTS) and could be used to discover novel modulators acting on GABA A ion channels.

          Related collections

          Most cited references19

          • Record: found
          • Abstract: found
          • Article: not found

          Which GABAA-receptor subtypes really occur in the brain?

          GABAA receptors are a heterogeneous family of ligand-gated ion channels responsible for mediating inhibitory neurotransmission in the CNS. Since the identification of mammalian cDNAs encoding 13 GABAA-receptor subunits, the composition of native receptor molecules and their localization in the brain has been an area of intense study. We conclude that the number of major subtypes is probably less than ten but their physiological roles have yet to be clearly defined and this represents the next step in GABAA-receptor research.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Subunit composition, distribution and function of GABA(A) receptor subtypes.

            GABA(A) receptors are the major inhibitory neurotransmitter receptors in the brain and are the site of action of many clinically important drugs. These receptors are composed of five subunits that can belong to eight different subunit classes. Depending on their subunit composition, these receptors exhibit distinct pharmacological and electrophysiological properties. Recent studies on recombinant and native GABA(A) receptors suggest the existence of far more receptor subtypes than previously assumed. Thus, receptors composed of one, two, three, four, or five different subunits might exist in the brain. Studies on the regional, cellular and subcellular distribution of GABA(A) receptor subunits, and on the co-localization of these subunits at the light and electron microscopic level for the first time provide information on the distribution of GABA(A) receptor subtypes in the brain. These studies will have to be complemented by electrophysiological and pharmacological studies on the respective recombinant and native receptors to finally identify the receptor subtypes present in the brain. The distinct cellular and subcellular location of individual receptor subtypes suggests that they exhibit specific functions in the brain that can be selectively modulated by subtype specific drugs. This conclusion is supported by the recent demonstration that different GABA(A) receptor subtypes mediate different effects of benzodiazepines. Together, these results should cause a revival of GABA(A) receptor research and strongly stimulate the development of drugs with a higher selectivity for alpha2-, alpha3-, or alpha5-subunit-containing receptor subtypes. Such drugs might exhibit quite selective clinical effects.
              Bookmark
              • Record: found
              • Abstract: not found
              • Article: not found

              International Union of Pharmacology. XV. Subtypes of gamma-aminobutyric acidA receptors: classification on the basis of subunit structure and receptor function.

                Bookmark

                Author and article information

                Contributors
                Role: Editor
                Journal
                PLoS One
                PLoS ONE
                plos
                plosone
                PLoS ONE
                Public Library of Science (San Francisco, USA )
                1932-6203
                2013
                14 March 2013
                : 8
                : 3
                : e59429
                Affiliations
                [1]AstraZeneca Research & Development, Discovery Sciences, Cellular Reagents & Assay Development, Mölndal, Sweden
                McLean Hospital/Harvard Medical School, United States of America
                Author notes

                Competing Interests: All authors are employed by AstraZeneca Research & Development, the funder of this study. There are no patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials, as detailed online in the guide for authors.

                Conceived and designed the experiments: TJ TN HPS. Performed the experiments: TJ HPS. Analyzed the data: TJ HPS. Contributed reagents/materials/analysis tools: TJ TN HPS. Wrote the paper: TJ TN HPS.

                Article
                PONE-D-12-34632
                10.1371/journal.pone.0059429
                3597608
                23516634
                a52b965b-6790-4244-b0cc-851570efcd0a
                Copyright @ 2013

                This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

                History
                : 7 November 2012
                : 14 February 2013
                Page count
                Pages: 7
                Funding
                The study was funded by AstraZeneca Research & Development. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
                Categories
                Research Article
                Biology
                Biochemistry
                Neurochemistry
                Neurochemicals
                Gamma-Aminobutyric Acid
                Proteins
                Ion Channels
                Recombinant Proteins
                Drug Discovery
                Small Molecules
                Molecular Cell Biology
                Cellular Types
                Eukaryotic Cells
                Neuroscience
                Cellular Neuroscience
                Ion Channels
                Neurochemistry
                Neurochemicals
                Gamma-Aminobutyric Acid
                Neurophysiology
                Central Nervous System

                Uncategorized
                Uncategorized

                Comments

                Comment on this article